You just read:

Daiichi Sankyo's HER2-Targeting Antibody Drug Conjugate DS-8201 Receives SAKIGAKE Designation for Gastric Cancer from Japan MHLW

News provided by

Daiichi Sankyo Company, Limited

Mar 27, 2018, 10:00 ET